These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 15748444)
1. [Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels]. Chen BA; Qian XJ; Cheng J; Gao F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):95-9. PubMed ID: 15748444 [TBL] [Abstract][Full Text] [Related]
2. [Effect of tetrandrine in combination with droloxifen on the expression of NF-kappaB protein in K562 and K562/A02 cell lines]. Su AL; Chen BA; Huang CY; Gao F; Cheng J; Xu WL; Shen HL; Sun XC; Cheng HY; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Chen NN; Zhao HH Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):321-4. PubMed ID: 18844070 [TBL] [Abstract][Full Text] [Related]
3. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo]. Wu D; Lin MF; Zhao XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123 [TBL] [Abstract][Full Text] [Related]
4. [Using protein chips to study mechanism underlying reversion of drug resistance in leukemia cells in tetrandrine alone or in combination with droloxifene]. Chen BA; Du J; Zhang CX; Cheng J; Gao F; Lu ZH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):999-1003. PubMed ID: 16403267 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087 [TBL] [Abstract][Full Text] [Related]
6. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein. Dilloo D; Hanenberg H; Lion T; Burdach S Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040 [TBL] [Abstract][Full Text] [Related]
7. [Detection of bcr-abl fusion gene mRNA level in K562/A02 cell line by real-time quantitative RT-PCR]. Chen BA; Zhou GN; Cheng J; Qiao C; Wu YJ; Li JY; Ding JH; Gao C; Zhao G; Wang J; Bao W; Song HH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):40-3. PubMed ID: 21362218 [TBL] [Abstract][Full Text] [Related]
8. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia]. Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325 [TBL] [Abstract][Full Text] [Related]
9. [Study on mismatch repair genes of chronic myeloid leukemia]. Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):103-6. PubMed ID: 16732964 [TBL] [Abstract][Full Text] [Related]
10. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells]. Li JE; Sun GL; Wu YL; Wu WL Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression. Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic effect of As2S2 on K562 cells and its mechanism. Li JE; Wu WL; Wang ZY; Sun GL Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of lithium chloride-induced proliferation inhibition and apoptosis of K562 leukemic cells]. Tang HR; He Q; Wang FC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):979-82. PubMed ID: 16403263 [TBL] [Abstract][Full Text] [Related]
16. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562]. Wang W; DU Y; Lin GQ; Li NN; Sun BZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411 [TBL] [Abstract][Full Text] [Related]
17. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
18. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells]. Wu Y; Chen Y; Hu J Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328 [TBL] [Abstract][Full Text] [Related]
19. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism]. Shi DX; Ma LM; Lu YJ; Bai B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284 [TBL] [Abstract][Full Text] [Related]
20. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA]. Liu JX; Liu JL; Wang GJ Ai Zheng; 2006 Nov; 25(11):1447-9. PubMed ID: 17094919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]